Adams Asset Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History

Adams Asset Advisors’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,000	Closed	-$51K	–	108
2019 Q2	$51K	Hold	10,000	–	–	0.01%	101
2019 Q1	$36K	Buy	+10,000	New	+$43.3K	﹤0.01%	96
2018 Q4	–	Sell	-10,000	Closed	-$58K	–	98
2018 Q3	$58K	Hold	10,000	–	–	0.01%	99
2018 Q2	$42K	Sell	10,000 -10,000	-50%	-$50.4K	﹤0.01%	97
2018 Q1	$88K	Hold	20,000	–	–	0.01%	95
2017 Q4	$105K	Hold	20,000	–	–	0.01%	95
2017 Q3	$122K	Hold	20,000	–	–	0.02%	93
2017 Q2	$145K	Hold	20,000	–	–	0.02%	91
2017 Q1	$106K	Hold	20,000	–	–	0.02%	92
2016 Q4	$144K	Hold	20,000	–	–	0.02%	92
2016 Q3	$187K	Hold	20,000	–	–	0.03%	94
2016 Q2	$126K	Hold	20,000	–	–	0.02%	90
2016 Q1	$110K	Buy	+20,000	New	+$75.2K	0.02%	92

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Adams Asset Advisors's PETX Position: Q3 2019 in Review

Adams Asset Advisors sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 10,000 shares — an estimated $51K sold.

Adams Asset Advisors first reported a position in PETX in Q1 2016 and held it in 13 quarters. The position peaked at $187K in Q3 2016. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Adams Asset Advisors reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Adams Asset Advisors sold 10,000 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $51K.
Adams Asset Advisors first reported a position in Aratana Therapeutics, Inc. in Q1 2016 and held it in 13 quarters.
Adams Asset Advisors's Aratana Therapeutics, Inc. position peaked at $187K in Q3 2016.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Adams Asset Advisors's 13F filing for Q3 2019, filed 8 Nov 2019.